The American Diabetes Association (ADA) is requesting applications for research focused on the impact of diabetes on COVID-19 and the impact of COVID-19 on diabetes and its complications.
Recent clinical results have shown that people with diabetes are at higher risk of death from COVID-19 and that COVID-19 drives an increased risk of hyperglycemia and other complications in those with and without diabetes. This is in addition to the risk due to advanced age and chronic disease. Both the biological mechanisms underlying this risk and how to minimize it remain poorly understood. There is an urgent need for research to understand the impact of diabetes on COVID-19 and vice versa. This is true at a basic and clinical level.
The goal of this RFA is to use a rapid application and review process to identify at least 10 grants of up to $100,000 each in this area and of high scientific merit for immediate funding.
Applications proposing COVID-19 impact on diabetes and its complications utilizing basic, clinical or translational research will be considered.
Deadline: May 22, 2020
Applicant must hold a PhD, MD, MD/PhD degree or equivalent health- or science-related degree and possess the necessary skills and training to carry out the proposed work.
Awards are limited to institutions within the United States and U.S. possessions. All investigators must be legally authorized to work in the U.S. Institutional confirmation of permission to work within the U.S. will be required for all applicants at the time of application submission.
At the time of application submission, applicants must hold a full-time faculty position or the equivalent at a U.S.-based university, university-affiliated research institution, or other non-profit research institution.
